Evidence map›Paper›PMID 28408438›Full record

ArticleThe EMBO journal2017

PRDM16 represses the type I interferon response in adipocytes to promote mitochondrial and thermogenic programing.

Megan Kissig, Jeff Ishibashi, Matthew J Harms, Hee-Woong Lim, Rachel R Stine, Kyoung-Jae Won, Patrick Seale

Open access · bronzeAbstract read
In one paragraph

Article in The EMBO journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed, 1 pooled it
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 1 synthesis or guideline pooled it, 73 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Megan KissigInstitute for Diabetes, Obesity & Metabolism, Smilow Center for Translational Research, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Jeff IshibashiInstitute for Diabetes, Obesity & Metabolism, Smilow Center for Translational Research, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Matthew J HarmsInstitute for Diabetes, Obesity & Metabolism, Smilow Center for Translational Research, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Hee-Woong LimInstitute for Diabetes, Obesity & Metabolism, Smilow Center for Translational Research, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.ORCID 0000-0001-8599-1808
Rachel R StineInstitute for Diabetes, Obesity & Metabolism, Smilow Center for Translational Research, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Kyoung-Jae WonInstitute for Diabetes, Obesity & Metabolism, Smilow Center for Translational Research, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Patrick SealeInstitute for Diabetes, Obesity & Metabolism, Smilow Center for Translational Research, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA sealep@upenn.edu.ORCID 0000-0001-7119-1615
University of Pennsylvania · US

Funding

VIRAL VECTOR COREP30DK019525 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI MITCHELL A. LAZAR · 1986 to 2026
$48.3M
Control of adipose function through a PRDM16/Type 1 Interferon AxisR01DK107589 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI SEALE, PATRICK · 2016 to 2018
$1.4M
Regulation of brown and beige adipocyte development through Ebf2R01DK103008 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI SEALE, PATRICK · 2014 to 2017
$1.4M
NIDDK NIH HHS P30 DK019525NIDDK NIH HHS R01 DK103008NIDDK NIH HHS R01 DK107589
6 · The paper itself

Abstract

Brown adipose has the potential to counteract obesity, and thus, identifying signaling pathways that regulate the activity of this tissue is of great clinical interest. PRDM16 is a transcription factor that activates brown fat-specific genes while repressing white fat and muscle-specific genes in adipocytes. Whether PRDM16 also controls other gene programs to regulate adipocyte function was unclear. Here, we identify a novel role for PRDM16 in suppressing type I interferon (IFN)-stimulated genes (ISGs), including

Indexed as

Gene Expression RegulationThermogenesisAdipocytesAnimalsDNA-Binding ProteinsInterferon Regulatory Factor-1Interferon Type IMiceMitochondriaSTAT1 Transcription FactorTranscription FactorsUncoupling Protein 1DNA-Binding ProteinsInterferon Regulatory Factor-1Interferon Type IIrf1 protein, mousePrdm16 protein, mouseStat1 protein, mouseSTAT1 Transcription FactorTranscription FactorsUcp1 protein, mouseUncoupling Protein 1brown adiposeinterferon regulatory factormitochondriaPrdm16Ucp1

Identifiers

PMID28408438
PMCPMC5452012
OpenAlexW2605879084

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.